搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Aspartyl protease inhibitor (API) CSB-YP856832OFO
CSB-EP856832OFO
CSB-BP856832OFO
CSB-MP856832OFO
CSB-EP856832OFO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein male abnormal 7 (mab-7), partial CSB-YP856833CXY
CSB-EP856833CXY
CSB-BP856833CXY
CSB-MP856833CXY
CSB-EP856833CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative galactocerebrosidase (C29E4.10), partial CSB-YP856834CXY
CSB-EP856834CXY
CSB-BP856834CXY
CSB-MP856834CXY
CSB-EP856834CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster N-alpha-acetyltransferase 30 (CG11412) CSB-YP856835DLU
CSB-EP856835DLU
CSB-BP856835DLU
CSB-MP856835DLU
CSB-EP856835DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Transmembrane protein 70 homolog, mitochondrial (CG7506), partial CSB-YP856836DLU1
CSB-EP856836DLU1
CSB-BP856836DLU1
CSB-MP856836DLU1
CSB-EP856836DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Netrin receptor unc-5 (unc-5), partial CSB-YP856837DLU
CSB-EP856837DLU
CSB-BP856837DLU
CSB-MP856837DLU
CSB-EP856837DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spodoptera frugiperda 40S ribosomal protein S16 (RpS16) CSB-YP856838FKQ
CSB-EP856838FKQ
CSB-BP856838FKQ
CSB-MP856838FKQ
CSB-EP856838FKQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Branchiostoma belcheri 60S ribosomal protein L38 (RPL38) CSB-YP856839BVX
CSB-EP856839BVX
CSB-BP856839BVX
CSB-MP856839BVX
CSB-EP856839BVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Branchiostoma belcheri Translationally-controlled tumor protein homolog CSB-YP856840BVX
CSB-EP856840BVX
CSB-BP856840BVX
CSB-MP856840BVX
CSB-EP856840BVX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schistosoma mansoni Translationally-controlled tumor protein homolog (TCTP) CSB-YP856841SXQ
CSB-EP856841SXQ
CSB-BP856841SXQ
CSB-MP856841SXQ
CSB-EP856841SXQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metallophosphoesterase 1 homolog (B0511.13), partial CSB-YP856842CXY1
CSB-EP856842CXY1
CSB-BP856842CXY1
CSB-MP856842CXY1
CSB-EP856842CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zinc finger CCCH domain-containing protein 14 (sut-2), partial CSB-YP856843CXY
CSB-EP856843CXY
CSB-BP856843CXY
CSB-MP856843CXY
CSB-EP856843CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable 26S proteasome complex subunit dss-1 (dss-1) CSB-YP856844CXY
CSB-EP856844CXY
CSB-BP856844CXY
CSB-MP856844CXY
CSB-EP856844CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Probable cyclin-dependent kinase 8 (cdk8) CSB-YP856845DKK
CSB-EP856845DKK
CSB-BP856845DKK
CSB-MP856845DKK
CSB-EP856845DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Apis mellifera Mushroom body large-type Kenyon cell-specific protein 1 (Mblk-1), partial CSB-YP856846DNK
CSB-EP856846DNK
CSB-BP856846DNK
CSB-MP856846DNK
CSB-EP856846DNK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Guanine nucleotide-binding protein subunit gamma (gpgA) CSB-YP856847DKK
CSB-EP856847DKK
CSB-BP856847DKK
CSB-MP856847DKK
CSB-EP856847DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serpentine receptor class beta-5 (srb-5), partial CSB-YP856848CXY1
CSB-EP856848CXY1
CSB-BP856848CXY1
CSB-MP856848CXY1
CSB-EP856848CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhinoceros unicornis ATP synthase subunit a (MT-ATP6), partial CSB-YP856849RCQ1
CSB-EP856849RCQ1
CSB-BP856849RCQ1
CSB-MP856849RCQ1
CSB-EP856849RCQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Putative G-protein coupled receptor B0244.10 (B0244.10), partial CSB-YP856850CXY
CSB-EP856850CXY
CSB-BP856850CXY
CSB-MP856850CXY
CSB-EP856850CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Kinesin-like protein Klp10A (Klp10A), partial CSB-YP856851DLU
CSB-EP856851DLU
CSB-BP856851DLU
CSB-MP856851DLU
CSB-EP856851DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>